AQST
$3.43
Aquestive Therapeutics
$.14
4.26%
AQST
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  ($0.42)
Revenue:  $9.82 Mil
Tuesday
Aug 3
7:55 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when AQST reports earnings?
Beat
Meet
Miss

Where is AQST's stock price going from here?
Up
Flat
Down
Stock chart of AQST
Analysts
Summary of analysts' recommendations for AQST
Score
Grade
Pivots
Resistance
$3.77
$3.61
$3.52

$3.36

Support
$3.27
$3.11
$3.02
Tweet
Growth
Description
Aquestive Therapeutics, Inc. is a specialty pharmaceutical company. It commercializes medicines to solve critical health care problems as well as engages on late-stage proprietary product pipeline which focuses on the treatment of diseases of central nervous system. Aquestive Therapeutics, Inc. is based in NJ, United States.